|
Market Closed -
Japan Exchange
04:30:00 21/08/26 pm AEST
|
5-day change | 1st Jan Change | ||
| 2,387.00 JPY | -1.28% |
|
+1.29% | +14.05% |
| 17/08 | CLSA Starts Astellas Pharma at Accumulate with 3,000 Yen Price Target | MT |
| 10/08 | AbCellera's menopause drug cuts hot flashes in mid-stage trial, shares surge | RE |
| Market Cap | 4,280B 26.92B 23.06B 21.58B 19.75B 37.07B 2,576B 37.56B 255B 99.42B 1,294B 101B 98.89B | P/E 2027 * |
11.6x | P/E 2028 * | 12.3x |
|---|---|---|---|---|---|
| Enterprise Value | 4,238B 26.66B 22.84B 21.37B 19.56B 36.71B 2,551B 37.19B 252B 98.44B 1,281B 100B 97.92B | EV / Sales 2027 * |
1.83x | EV / Sales 2028 * | 1.8x |
| Free-Float |
98.88% | Yield 2027 * |
3.36% | Yield 2028 * | 3.47% |
Last Transcript: Astellas Pharma Inc.
| 1 day | -1.28% | ||
| 1 week | +1.29% | ||
| Current month | +8.40% | ||
| 1 month | +9.72% | ||
| 3 months | +5.18% | ||
| 6 months | -3.61% | ||
| Current year | +14.05% |
| 1 week | 2,250 |  | 2,418.5 |
| 1 month | 2,125 | | 2,418.5 |
| Current year | 2,041 | | 2,717 |
| 1 year | 1,557.5 | | 2,717 |
| 3 years | 1,243.5 | | 2,717 |
| 5 years | 1,243.5 | | 2,717 |
| 10 years | 1,243.5 | | 2,717 |
| Manager | Title | Age | Since |
|---|---|---|---|
Naoki Okamura
CEO | Chief Executive Officer | 63 | 10/02/2023 |
Kitamura Atsushi
DFI | Director of Finance/CFO | 54 | 01/11/2023 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Enyedy
BRD | Director/Board Member | 61 | 19/06/2025 |
Tomoko Aramaki
BRD | Director/Board Member | 57 | 01/06/2024 |
Kenji Yasukawa
CHM | Chairman | 66 | 10/02/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.28% | +1.29% | +41.03% | +6.61% | 26.92B | |
| +0.88% | +6.38% | +76.40% | +126.75% | 1,119B | |
| +1.07% | +3.80% | +50.73% | +62.78% | 651B | |
| +1.20% | +6.21% | +25.81% | +78.74% | 468B | |
| +1.02% | +5.77% | +43.63% | +48.43% | 374B | |
| +0.85% | +4.07% | +24.97% | +40.58% | 302B | |
| +1.26% | +6.81% | +2.27% | +14.41% | 259B | |
| +1.88% | +5.81% | +49.57% | +70.53% | 238B | |
| +1.59% | +2.09% | -17.33% | -52.62% | 208B | |
| +1.87% | +5.61% | +27.32% | +91.38% | 181B | |
| Average | +1.03% | +4.61% | +32.44% | +48.76% | 382.68B | |
| Weighted average by Cap. | +1.12% | +5.06% | +44.24% | +72.18% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 2,315B 14.57B 12.48B 11.67B 10.69B 20.05B 1,394B 20.32B 138B 53.79B 700B 54.69B 53.5B | 2,137B 13.44B 11.51B 10.77B 9.86B 18.5B 1,286B 18.75B 127B 49.63B 646B 50.46B 49.37B |
| Net income | 356B 2.24B 1.92B 1.79B 1.64B 3.08B 214B 3.12B 21.2B 8.27B 108B 8.4B 8.22B | 333B 2.09B 1.79B 1.68B 1.53B 2.88B 200B 2.92B 19.81B 7.72B 101B 7.85B 7.68B |
| Net Debt | -41.87B -263M -226M -211M -193M -363M -25.2B -367M -2.49B -973M -12.66B -989M -968M | -439B -2.76B -2.37B -2.21B -2.03B -3.8B -264B -3.85B -26.15B -10.2B -133B -10.37B -10.14B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/08/26 | JPY 2,387.00 | -1.28% | 4,564,900 |
| 20/08/26 | JPY 2,418.00 | +3.47% | 7,092,700 |
| 19/08/26 | JPY 2,337.00 | +1.15% | 8,354,700 |
| 18/08/26 | JPY 2,310.50 | +1.20% | 4,808,500 |
| 17/08/26 | JPY 2,283.00 | -3.12% | 3,904,500 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4503 Stock
Select your edition
All financial news and data tailored to specific country editions
